GOVERNEUR, N.Y. – Kinney Drugs has now opened both walk-ins and appointments for a second dose of seasonal COVID-19 vaccine for eligible individuals. In October, the CDC recommended that individuals aged 65 and older and those who are moderately to severely immunocompromised receive a second dose of seasonal COVID-19 vaccine two to six months after their last dose.
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose. Kinney Drugs accepts walk-ins; however, appointments are encouraged to ensure the promptest service. The COVID-19 vaccine can be co-administered with all other approved vaccines.
“CDC data show the importance of vaccination to protect people who are most at risk for severe outcomes of COVID, such as older adults and anyone with an immunocompromising condition,” said John Marraffa, president of Kinney Drugs. “We know that vaccination can restore and enhance protection against those viruses that are causing infections and hospitalizations in our region, including RSV, COVID, and influenza. And flu is spiking right now, especially in older populations. So, if patients haven’t received their flu vaccine, it’s not too late for this year. As always, our pharmacists stand ready to assist with immunizations and other healthcare needs,” he added.
Kinney Drugs expands COVID-19 vaccine access for high-risk individuals
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose.
Latest
PEPCID delivers fast relief during football playoffs with Derrick Henry
PEPCID is teaming with running back Derrick Henry to bring the campaign to life and showcase how Pepcid Complete matches the strength and speed that Derrick brings to the field with fast heartburn relief that lasts all day.
L'Oréal Professional Products unveils Landmark Academy in Hudson Yards
Flagship destination redefines the future of education.
Council on Responsible Nutrition welcomes new members
New member applications are reviewed by CRN’s board of directors quarterly, with the next review scheduled for March.
2026 Health Care Outlook: Steve Anderson, NACDS
By Steve Anderson, president and CEO of the National Association of Chain Drug Stores